BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15461628)

  • 21. Clinical spectrum of Glanzmann's thrombasthenia.
    Badhe BA; Jayanthi S; Datta T
    Indian J Pathol Microbiol; 2000 Jul; 43(3):297-302. PubMed ID: 11218676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neonatal isoimmune thrombocytopenia by anti-GP IIb/IIIa].
    Kiefel V; Meyer E; Greinacher A; Kroll H; Mueller-Eckhardt C
    Beitr Infusionsther; 1992; 30():450-3. PubMed ID: 1284758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glanzmann's thrombasthenia in pregnancy: a case and review of the literature.
    Sherer DM; Lerner R
    Am J Perinatol; 1999; 16(6):297-301. PubMed ID: 10586983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran.
    Farsinejad A; Farajollahi MM; Kazemi A; Saemi N; Faranoush M
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):613-8. PubMed ID: 23912132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dental considerations for a Glanzmann's thrombasthenia patient: case report.
    Bisch FC; Bowen KJ; Hanson BS; Kudryk VL; Billman MA
    J Periodontol; 1996 May; 67(5):536-40. PubMed ID: 8724714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired Glanzmann's thrombasthenia associated with acute lymphoblastic leukemia.
    André JM; Galambrun C; Trzeciak MC; Dargaud Y; Kaplan-Gouet C; Jallu V; Bertrand Y
    J Pediatr Hematol Oncol; 2005 Oct; 27(10):554-7. PubMed ID: 16217260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures.
    d'Oiron R; Ménart C; Trzeciak MC; Nurden P; Fressinaud E; Dreyfus M; Laurian Y; Négrier C
    Thromb Haemost; 2000 May; 83(5):644-7. PubMed ID: 10823254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mutations in GP IIb gene in Glanzmann's thrombasthenia from India.
    Vijapurkar M; Ghosh K; Shetty S
    Platelets; 2009 Feb; 20(1):35-40. PubMed ID: 19172520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostasis in Glanzmann's thrombasthenia (GT): GT platelets interfere with the aggregation of normal platelets.
    Jennings LK; Wang WC; Jackson CW; Fox CF; Bell A
    Am J Pediatr Hematol Oncol; 1991; 13(1):84-90. PubMed ID: 2029084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glanzmann's thrombasthenia in North Indians: sub classification and carrier detection by flow cytometry.
    Kannan M; Ahmad F; Yadav BK; Anand M; Jain P; Kumar R; Saxena R
    Platelets; 2009 Feb; 20(1):12-5. PubMed ID: 19172516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of carriers in Glanzmann's thrombasthenia.
    Zonneveld GT; van Leeuwen EF; Sturk A; ten Cate JW
    Thromb Haemost; 1983 Jun; 49(3):182-6. PubMed ID: 6224309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.
    Zahran AM; Saad K; Elsayh KI; Alblihed MA; Embaby M
    Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):565-571. PubMed ID: 28161816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary artery bypass grafting in a patient with Glanzmann's thrombasthenia.
    Ryckman JG; Hall S; Serra J
    J Card Surg; 2005; 20(6):555-6. PubMed ID: 16309410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glanzmann's thrombasthenia: modulation of clinical phenotype by alpha2C807T gene polymorphism.
    D'Andrea G; Margaglione M;
    Haematologica; 2003 Dec; 88(12):1378-82. PubMed ID: 14687991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy in a patient of Glanzmann's thrombasthenia with antiplatelet antibodies.
    Kashyap R; Kriplani A; Saxena R; Takkar D; Choudhry VP
    J Obstet Gynaecol Res; 1997 Jun; 23(3):247-50. PubMed ID: 9255036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of RFLP using TspRI for carrier detection in Glanzmann's thrombasthenia: a report on two families.
    Kannan M; Yadav BK; Ahmad F; Saxena R
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e158-62. PubMed ID: 19170775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Unusual features in Glanzmann thrombasthenia; proliferation of B-lymphocytes, lead poisoning].
    Bucher U
    Schweiz Med Wochenschr; 1988 Oct; 118(42):1510-27. PubMed ID: 3059486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
    Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
    Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired thrombasthenia due to inhibitory effect of glycoprotein IIbIIIa autoantibodies.
    Blickstein D; Dardik R; Rosenthal E; Lahav J; Molad Y; Inbal A
    Isr Med Assoc J; 2014 May; 16(5):307-10. PubMed ID: 24979837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry.
    Albanyan A; Al-Musa A; AlNounou R; Al Zahrani H; Nasr R; AlJefri A; Saleh M; Malik A; Masmali H; Owaidah T
    Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.